PCI or CABG: which patients and at what cost?
作者信息
Gershlick Tony, Thomas Martyn
机构信息
Glenfield Hospital, Leicester, UK.
出版信息
Heart. 2007 Oct;93(10):1188-90. doi: 10.1136/hrt.2007.124750.
Abstract
摘要
相似文献
1
PCI or CABG: which patients and at what cost?经皮冠状动脉介入治疗（PCI）还是冠状动脉旁路移植术（CABG）：哪些患者适用，成本几何？
Heart. 2007 Oct;93(10):1188-90. doi: 10.1136/hrt.2007.124750.
2
Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease.稳定型冠状动脉疾病中的缺血负荷、治疗分配及预后
Circ Cardiovasc Imaging. 2011 Nov;4(6):746-53. doi: 10.1161/CIRCIMAGING.111.970111.
3
Comparison of costs of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft surgery (CABG) for patients with angina pectoris.
Eur Heart J. 1991 Feb;12(2):288. doi: 10.1093/oxfordjournals.eurheartj.a059885.
4
[Cost analysis of percutaneous coronary intervention and coronary artery bypass grafting in Japan and USA].
Nihon Rinsho. 2003 Apr;61 Suppl 4:632-7.
5
Guide to coronary bypass. The beat goes on.冠状动脉搭桥指南。心跳仍在继续。
Health Serv J. 1998 Jun 25;108(5610):suppl 18-9.
6
[Comparison of long-term clinical results and cost-effectiveness of percutaneous coronary angioplasty and coronary artery bypass grafting].经皮冠状动脉腔内血管成形术与冠状动脉旁路移植术的长期临床结果及成本效益比较
Nihon Kyobu Geka Gakkai Zasshi. 1994 Feb;42(2):222-7.
7
Revascularisation for acute coronary syndromes: PCI or CABG?急性冠状动脉综合征的血运重建：经皮冠状动脉介入治疗还是冠状动脉旁路移植术？
Heart. 2003 Sep;89(9):967-70. doi: 10.1136/heart.89.9.967.
8
Does prior PCI increase the risk of subsequent CABG?既往经皮冠状动脉介入治疗（PCI）会增加后续冠状动脉旁路移植术（CABG）的风险吗？
Eur Heart J. 2008 Mar;29(5):573-5. doi: 10.1093/eurheartj/ehm645. Epub 2008 Feb 19.
9
Do hybrid procedures have proven clinical utility and are they the wave of the future? : hybrid procedures have proven clinical utility and are the wave of the future.杂交手术是否已证明具有临床实用性，它们会是未来的潮流吗？：杂交手术已证明具有临床实用性，并且是未来的潮流。
Circulation. 2012 May 22;125(20):2492-503; discussion 2503. doi: 10.1161/CIRCULATIONAHA.111.041186.
10
Revascularization trumps medicine for patients with type 2 diabetes mellitus and chronic angina (or does it?).对于2型糖尿病合并慢性心绞痛患者，血管重建术优于药物治疗（真的如此吗？）
Circulation. 2011 Apr 12;123(14):1489-91. doi: 10.1161/CIRCULATIONAHA.111.022780. Epub 2011 Mar 28.
引用本文的文献
1
Preoperative factors affecting cost and length of stay for isolated off-pump coronary artery bypass grafting: hierarchical linear model analysis.影响单纯非体外循环冠状动脉搭桥术成本和住院时间的术前因素：分层线性模型分析
BMJ Open. 2015 Nov 17;5(11):e008750. doi: 10.1136/bmjopen-2015-008750.
2
Angiographic estimation of atherosclerotic disease burden in a coronary artery fed by collaterals: a potential pitfall in decision for revascularization.通过侧支循环供血的冠状动脉中动脉粥样硬化疾病负担的血管造影评估：血管重建决策中的一个潜在陷阱。
Vasc Health Risk Manag. 2011;7:165-7. doi: 10.2147/VHRM.S18483. Epub 2011 Mar 22.
本文引用的文献
1
Optimal medical therapy with or without PCI for stable coronary disease.稳定型冠心病接受或不接受经皮冠状动脉介入治疗的优化药物治疗
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.
2
Coronary revascularisation.冠状动脉血运重建。
BMJ. 2007 Mar 24;334(7594):593-4. doi: 10.1136/bmj.39154.552280.BE.
3
Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.药物、血管成形术或手术研究（MASS II）的五年随访：一项针对多支冠状动脉疾病三种治疗策略的随机对照临床试验
Circulation. 2007 Mar 6;115(9):1082-9. doi: 10.1161/CIRCULATIONAHA.106.625475.
4
Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study.关于心绞痛替代治疗临床适宜决策的成本效益：前瞻性观察性研究
BMJ. 2007 Mar 24;334(7594):624. doi: 10.1136/bmj.39129.442164.55. Epub 2007 Mar 5.
5
Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.左前降支孤立病变的微创胸廓内动脉搭桥术与经皮血管重建术的荟萃分析。
BMJ. 2007 Mar 24;334(7594):617. doi: 10.1136/bmj.39106.476215.BE. Epub 2007 Mar 2.
6
Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.左前降支孤立病变的微创胸廓内动脉搭桥术与经皮血管重建术的成本效益分析
BMJ. 2007 Mar 24;334(7594):621. doi: 10.1136/bmj.39112.480023.BE. Epub 2007 Mar 2.
7
Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.冠状动脉搭桥手术后使用二级预防药物的相关结果。
Ann Thorac Surg. 2007 Mar;83(3):993-1001. doi: 10.1016/j.athoracsur.2006.10.046.
8
The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).
Eur Heart J. 2007 Feb;28(4):433-42. doi: 10.1093/eurheartj/ehl539. Epub 2007 Jan 31.
9
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.紫杉醇药物洗脱支架冠状动脉介入治疗与心脏手术协同作用（SYNTAX）研究：设计、原理及导入阶段
Am Heart J. 2006 Jun;151(6):1194-204. doi: 10.1016/j.ahj.2005.07.017.
10
Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial.当代药物洗脱支架时代的冠状动脉支架血栓形成：来自ERACI III试验的见解。
J Am Coll Cardiol. 2006 Jan 3;47(1):205-7. doi: 10.1016/j.jacc.2005.10.016. Epub 2005 Dec 9.
Zotero 插件